CellaVision AB
SE-MF-000002377 · Sweden · Lund
CellaVision AB is registered in the European database on medical devices as a manufacturer, with 48 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
Most frequent device types declared: CellaVision® Bone Marrow Aspirate Application.
Devices declared under this manufacturer
- Adv. RBC and Body Fluid Non-Expiring License
- Body Fluid Application
- CellaVision® Body Fluid Application DM9600 Non-Expiring License
- CellaVision® DM Software DC-1 Version 7.2
- CellaVision® DM Software DI-60 Upgrade to 6.0.x incl. Localization DVD
- CellaVision® DM Software DM1200 Upgrade from 4.0.x to 7.0.x
- CellaVision® DM Software DM1200 Upgrade to 6.0.x incl. Localization DV
- CellaVision® DM Software DM9600 Upgrade to 6.0.x incl. Localization DV
- CellaVision® DM9600
- CellaVision® Remote Review Enterprise Edition Upgrade from Citrix Read
- CellaVision® Remote Review Single Edition
- CellaVision® Remote Review Team Edition
Showing 12 of 48 declared devices.
Catalogue references include AG241722, AG516335, AW736222, CDMS-127040, CK257542, CRRS-ENXXUP.
European nomenclature codes declared: W02029092, W02029099, W02029085.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | CELLAVISION AB (SE) · FDA 3003630693 |
| Devices in EUDAMED | 48 |
| Country of registration | Sweden |
Device-level evidence
| Devices with a numeric GTIN | 48 |
|---|---|
| Found in the U.S. device database | 18 |
| Share | 37.5 % |
Canadian market access
| Health Canada licence listing | Licensed in Canada |
|---|---|
| Matched entry | CELLAVISION, INC. |
North American profile: Both markets. CellaVision AB is registered in both the United States and Canada.